Neurotech International Limited (NTI.AX)
AUD 0.05
(-3.57%)
AUD 0.05
(-3.57%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.59 Million | -6.31 Million | -2.95 Million | -2.31 Million | -682.83 Thousand | -2.54 Million |
| Net Income | -5.06 Million | -7.79 Million | -3.36 Million | -7.43 Million | -1.71 Million | -4.8 Million |
| Depreciation & Amortization | 583.00 | 1744.00 | 588.00 | - | 81.08 Thousand | - |
| Deferred income taxes | - | -284.85 Thousand | 195.28 Thousand | - | 263.84 Thousand | - |
| Stock-based compensation | 2.18 Million | 876.59 Thousand | 83.95 Thousand | 4.99 Million | 129.29 Thousand | 105.55 Thousand |
| Change in working capital | -1.7 Million | 596.64 Thousand | 323.14 Thousand | 353.92 Thousand | 545.23 Thousand | 138.75 Thousand |
| Other non-cash items | 3.63 Million | 284.85 Thousand | -195.86 Thousand | -230.79 Thousand | 11.14 Thousand | 2.01 Million |
| Investing Cash Flow | - | - | -3205.00 | - | - | - |
| Investments in PPE | 4.59 Million | - | -3205.00 | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 11.19 Million | 9.44 Million | 26.4 Thousand | 7.13 Million | 220.5 Thousand | 804.99 Thousand |
| Debt repayment | - | - | - | -46.58 Thousand | -79.49 Thousand | -96.28 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -443.47 Thousand | - | -74.97 Thousand |
| Common Stock Issuance | 11.19 Million | 9.44 Million | 26.4 Thousand | 7.17 Million | 300 Thousand | 708.71 Thousand |
| Other Financing Activities | 11.19 Million | 9.44 Million | 26.4 Thousand | 7.13 Million | 220.5 Thousand | 997.57 Thousand |
| Accounts receivables | -60.49 Thousand | -158.07 Thousand | 43.46 Thousand | -116.82 Thousand | 116.37 Thousand | 130.1 Thousand |
| Accounts payables | -1.4 Million | 753.88 Thousand | 244.14 Thousand | 471.52 Thousand | 438.92 Thousand | -116.61 Thousand |
| Inventory | 7781.00 | -579.00 | -7202.00 | - | - | 70.98 Thousand |
| Other working capital | -252.74 Thousand | 1418.00 | 42.73 Thousand | -772.00 | -10.06 Thousand | 54.28 Thousand |
| Cash at beginning of period | 3.01 Million | 1.88 Million | 4.82 Million | 12.35 Thousand | 474.68 Thousand | 2.21 Million |
| Cash at end of period | 2.11 Million | 3.01 Million | 1.88 Million | 4.82 Million | 12.35 Thousand | 474.68 Thousand |
| Capital Expenditure | 4.59 Million | - | -3205.00 | - | - | - |
| Effect of forex changes on cash | - | - | -15 Thousand | 772.00 | - | - |
| Net cash flow / Change in cash | -900.31 Thousand | 1.13 Million | -2.94 Million | 4.81 Million | -462.32 Thousand | -1.73 Million |
| Free Cash Flow | - | -6.31 Million | -2.95 Million | -2.31 Million | -682.83 Thousand | -2.54 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.06 Million | -4.34 Million | -728.77 Thousand | -4.25 Million | -7.79 Million | -3.53 Million |
| Depreciation & Amortization | 583.00 | 290.00 | 293.00 | 1156.00 | 1744.00 | 588.00 |
| Deferred income taxes | - | - | - | 867.79 Thousand | -284.85 Thousand | - |
| Stock-based compensation | - | 1.25 Million | 926.4 Thousand | -711.44 Thousand | 876.59 Thousand | 1.58 Million |
| Change in working capital | -1.7 Million | -305.45 Thousand | - | -157.24 Thousand | 596.64 Thousand | - |
| Other non-cash items | 3.63 Million | -334.79 Thousand | -141.23 Thousand | 860.07 Thousand | 284.85 Thousand | 616.65 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 11.19 Million | 10.87 Million | 323.92 Thousand | 319.92 Thousand | 9.44 Million | 9.12 Million |
| Debt repayment | - | - | -63.87 Thousand | - | - | -54.74 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 11.19 Million | 10.93 Million | 260.05 Thousand | 374.67 Thousand | 9.44 Million | 9.07 Million |
| Other Financing Activities | - | 10.87 Million | 260.05 Thousand | 319.92 Thousand | 9.44 Million | 9.07 Million |
| Accounts receivables | -60.49 Thousand | -60.49 Thousand | - | -158.07 Thousand | -158.07 Thousand | - |
| Accounts payables | -1.4 Million | - | - | - | 753.88 Thousand | - |
| Inventory | 7781.00 | 7781.00 | - | -579.00 | -579.00 | - |
| Other working capital | -252.74 Thousand | -252.74 Thousand | - | 1418.00 | 1418.00 | - |
| Cash at beginning of period | 3.01 Million | 4.47 Million | 3.01 Million | 8.08 Million | 1.88 Million | 3.02 Million |
| Cash at end of period | 2.11 Million | 2.11 Million | 4.46 Million | 3.01 Million | 3.01 Million | 8.08 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -900.31 Thousand | -2.36 Million | 1.45 Million | -5.07 Million | 1.13 Million | 5.06 Million |
| Free Cash Flow | -4.59 Million | -3.72 Million | -870.29 Thousand | -3.39 Million | -6.31 Million | -2.92 Million |
HRGLF
NANO
SBILIFE
ONFO
TREX
GAPB